Delivery Order SPE2DB22D3004-SPE2DB23FPY33
Award Date 4/24/23
Potential Completion Date 4/25/23
Potential Value $6.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,149.97 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron hydrochloride tablets. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables Cencora, Inc. to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,685.70 firm-fixed-price delivery order is for the supply of 500 units of Ondansetron HCL 4 mg tablets. The award has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This is a $48,701.59 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Ondansetron Hydrochloride tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a...
- This federal contract award, valued at $7,307.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,563,501,307 tablets of Ondansetron Hydrochloride 8 mg. The contract has an ultimate completion date of February 1, 2024 and is structured as a Firm Fixed Price Delivery Order. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ondansetron HCL 4 mg tablets. The contract, valued at $1,590.86, is a Firm Fixed Price agreement with a completion date of May 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of ondansetron hydrochloride 4 mg tablets. The $2,518.38 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,092.97 firm fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,140.58 firm fixed-price delivery order is for the supply of 4,560,207,119 units of Ondansetron HCL 4 mg tablets. The contract has a completion date of March 10, 2023 and was awarded on March 9, 2023. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,733.48 Firm Fixed Price Delivery Order is for the supply of 4 mg Ondansetron Hydrochloride tablets in 30-count packages. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ondansetron HCL 4 mg Tablets. The contract has a ceiling value of $13,034.96 and an ultimate completion date of May 22, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running...